[5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone
C17H18FN7OS — CID 146418417
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone
[5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone (PubChem CID 146418417) has the molecular formula C17H18FN7OS and a molecular weight of 387.44 g/mol. Its IUPAC name is [5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone.
Molecular Properties
| Compound Name | [5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone |
|---|---|
| PubChem CID | 146418417 |
| Molecular Formula | C17H18FN7OS |
| Molecular Weight | 387.44 g/mol |
| Exact Mass | 387.13 |
| IUPAC Name | [5-[1-(5-fluoro-3-pyridinyl)ethylamino]-2-methyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]-imidazolidin-1-ylmethanone |
| SMILES | Cc1nc2nc(NC(C)c3cncc(F)c3)nc(C(=O)N3CCNC3)c2s1 |
| InChI | InChI=1S/C17H18FN7OS/c1-9(11-5-12(18)7-20-6-11)21-17-23-13(16(26)25-4-3-19-8-25)14-15(24-17)22-10(2)27-14/h5-7,9,19H,3-4,8H2,1-2H3,(H,21,23,24) |
| InChIKey | GLNCREOLEUEPSY-UHFFFAOYSA-N |
| XLogP | 2.10 |
| TPSA | 95.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.44 |
| LogP ≤ 5 | 2.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146418417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.